EUVIMEDEUVIMED entdecken
Open Access

ent-Verticilide B1 Inhibits Type 2 Ryanodine Receptor Channels and is Antiarrhythmic in Casq2−/− Mice

Aaron Gochman, Tri Q Do, Kyungsoo Kim, Jacob A Schwarz, Madelaine P Thorpe iD, Daniel J Blackwell, Paxton A Ritschel, Abigail N Smith iD, Robyn T Rebbeck, Wendell S Akers, Razvan L Cornea, Derek R Laver iD und 2 weitere

Molecular Pharmacology · 2024-03 · 105 (3) · 194-201

DOI: 10.1124/molpharm.123.000752 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmacology, 2024-03. Verfasst von Aaron Gochman und 13 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt Center for Arrhythmia Research and Therapeutics, Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, Tenne…. Hauptthemen laut MEDLINE: Depsipeptides, Biological Products. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DepsipeptidesBiological ProductsMiceAnimalsAnti-Arrhythmia AgentsRyanodine Receptor Calcium Release ChannelArrhythmias, CardiacDeath, Sudden, CardiacMyocytes, CardiacCalcium

Substanzen

Anti-Arrhythmia AgentsRyanodine Receptor Calcium Release ChannelverticilideDepsipeptidesBiological ProductsCalcium

Autor:innen und Institutionen

  • Vanderbilt Center for Arrhythmia Research and Therapeutics, Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee (A.G., T.Q.D. K.K., D.J.B., P.A.R., B.C.K.); Vanderbilt Departmen…

ORCID-Profile: Madelaine P Thorpe, Abigail N Smith, Derek R Laver, Jeffrey N Johnston, Bjorn C Knollmann

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Gochman, A., Do, T. Q., Kim, K., Schwarz, J. A., Thorpe, M. P., Blackwell, D. J., Ritschel, P. A., Smith, A. N., Rebbeck, R. T., Akers, W. S., Cornea, R. L., Laver, D. R., Johnston, J. N., & Knollmann, B. C. (2024). ent-Verticilide B1 Inhibits Type 2 Ryanodine Receptor Channels and is Antiarrhythmic in Casq2−/− Mice. Molecular Pharmacology, 105(3), 194-201. https://doi.org/10.1124/molpharm.123.000752

Vancouver

Gochman A, Do TQ, Kim K, Schwarz JA, Thorpe MP, Blackwell DJ, et al. ent-Verticilide B1 Inhibits Type 2 Ryanodine Receptor Channels and is Antiarrhythmic in Casq2−/− Mice. Molecular Pharmacology. 2024;105(3):194-201. doi:10.1124/molpharm.123.000752

BibTeX
@article{Gochman2024,
  author = {Gochman, Aaron and Do, Tri Q and Kim, Kyungsoo and Schwarz, Jacob A and Thorpe, Madelaine P and Blackwell, Daniel J and Ritschel, Paxton A and Smith, Abigail N and Rebbeck, Robyn T and Akers, Wendell S and Cornea, Razvan L and Laver, Derek R and Johnston, Jeffrey N and Knollmann, Bjorn C},
  title = {ent-Verticilide B1 Inhibits Type 2 Ryanodine Receptor Channels and is Antiarrhythmic in Casq2−/− Mice},
  journal = {Molecular Pharmacology},
  year = {2024},
  volume = {105},
  number = {3},
  pages = {194--201},
  doi = {10.1124/molpharm.123.000752}
}
Kostenlos starten →